Chronic Pancreatitis I: Introduction
Chronic Pancreatitis II: Collaborative Care
Acute Pancreatitis II: Clinical Manifestations and Management
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 18, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
Massimo Falconi1, Domenico Tamburrino2, Elena Buzzetti3
1Chirurgia del Pancreas, Pancreas Translational & Clinical Research Center, Ospedale San Raffaele, Università "Vita e Salute", Milano.
Pancreatic cancer survival is improving due to better patient selection for surgery and advances in oncological therapies. Adjuvant and neoadjuvant treatments aim to improve outcomes for resectable and locally advanced pancreatic cancer, respectively.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: